PHGDH: a metabolic switch in tumor drug resistance and a therapeutic target.

Saved in:
Bibliographic Details
Title: PHGDH: a metabolic switch in tumor drug resistance and a therapeutic target.
Authors: Shi SS; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China; Zhejiang Key Laboratory of Green Manufacturing Technology for Chemical Drugs, Deqing 313200, PR China., Chen SY; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China., Zhang W; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China., Rao GW; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China; Zhejiang Key Laboratory of Green Manufacturing Technology for Chemical Drugs, Deqing 313200, PR China. Electronic address: rgw@zjut.edu.cn., Zheng Q; Department of Medical Oncology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, PR China; Core Facility, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, PR China. Electronic address: zhengquan@wmu.edu.cn.
Source: Drug discovery today [Drug Discov Today] 2026 May; Vol. 31 (3), pp. 104640. Date of Electronic Publication: 2026 Mar 11.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9604391 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5832 (Electronic) Linking ISSN: 13596446 NLM ISO Abbreviation: Drug Discov Today Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-5832
DOI:10.1016/j.drudis.2026.104640